June 17, 2020 / 12:19 PM / a month ago

BRIEF-Akero Therapeutics Doses First Patient In Expansion Of Phase 2A Trial In Nash

June 17 (Reuters) - Akero Therapeutics Inc:

* AKERO THERAPEUTICS DOSES FIRST PATIENT IN EXPANSION OF PHASE 2A TRIAL IN NASH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below